Pituitary adenylate cyclase–activating polypeptide blockade in migraine and the transformation of clinical practice
Headache: The Journal of Head and Face Pain · 2026-07 · 66 (7) · 1657-1659
DOI: 10.1111/head.70151 ↗At a glance
Journal article in Headache: The Journal of Head and Face Pain, published online on 2026-06-14. Written by Sait Ashina. Institution: Department of Neurology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA. 9 references.
Abstract (original language)
Intet abstract tilgængeligt.
Subjects
Author keywords
Authors and institutions
- Department of Neurology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
- Department of Anesthesia, Critical Care and Pain Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
ORCID profiles: Sait Ashina
Cite
APA
Ashina, S. (2026). Pituitary adenylate cyclase–activating polypeptide blockade in migraine and the transformation of clinical practice. Headache: The Journal of Head and Face Pain, 66(7), 1657-1659. https://doi.org/10.1111/head.70151
Vancouver
Ashina S. Pituitary adenylate cyclase–activating polypeptide blockade in migraine and the transformation of clinical practice. Headache: The Journal of Head and Face Pain. 2026;66(7):1657-1659. doi:10.1111/head.70151
BibTeX
@article{Ashina2026,
author = {Ashina, Sait},
title = {Pituitary adenylate cyclase–activating polypeptide blockade in migraine and the transformation of clinical practice},
journal = {Headache: The Journal of Head and Face Pain},
year = {2026},
volume = {66},
number = {7},
pages = {1657--1659},
doi = {10.1111/head.70151}
}
EUVIMED